MRVIMaravai LifeSciences Holdings, Inc.
$7.47+177% 1Y
$7.47
$2.6952 weeks$8.99
MRVI in its own filings
MRVI's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
110
Events found in the filings · across 421 filings · the record starts in 2020
- Hard flags
- 3
Hard flags
- Most recent filing
- Aug 7, 2026
Most recent filing · Form 10-Q
- Record starts
- Oct 8, 2020
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Restatement admitted (non-reliance)past_3y
- 2025-03-18
- Change in certifying accountantpast_3y
- 2025-07-18
- Late periodic reportpast_3y
- 2025-03-04
- SEC comment-letter activity25 occurrences
- 2025-02-20
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Second quarter 2026 total revenue up 9% from prior year.Earnings release · press release
- Jun 3, 2026On June 2, 2026, Maravai Intermediate Holdings, LLC (the “Borrower”) and Maravai Topco Holdings, LLC (“Topco”), each a consolidated subsidiary controlled by Maravai LifeSciences Holdings, Inc., entered into a Credit Agreement (the “New Credit Agreement”) with certain lenders and issuing banks party thereto and BSP …Material agreement entered · Form 8-K
- May 7, 2026First quarter 2026 total revenue up 41% from prior year.Earnings release · press release
- Feb 25, 2026Organizational restructuring and operating cost reduction ahead of plan.Earnings release · press release
- Nov 6, 2025Organizational restructuring and operating cost reduction initiatives on track.Earnings release · press release
- Oct 27, 2025On October 21, 2025, as part of Maravai LifeSciences Holdings, Inc.’s (the “Company”) efforts to rationalize the size of its Board of Directors (the “Board”) and reduce administrative costs, Benjamin Daverman, Jessica Hopfield, PhD, and Murali Prahalad, PhD each agreed to voluntarily resign from the Board effective as …Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…